Industry Expert Warns Gym Operators Against Costly Access Control Vendor Lock-In
Tuesday 8 July, 2025 Nortech MD reveals how traditional systems create "integration…
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig)…
